1Alectinib, a novel ALK inhibitorLI Da-wei, LIU Zheng-ping, ZHANG Jian-qiang1561-15652Evaluation of pharmaceutical industry structure optimization in ChinaLUO Wen-hua, SUN Li-hua, ZHOU Jing1566-15713Enlightenment of the implementation of DMF notification system in America for pharmaceutical packaging administration system reform in ChinaLIU Dong, WEI Jing1572-15764On the expression of prescription in the instruction of traditional Chinese medicineHAN Wei, ZHOU Yue-hua1577-15805Effect of (R, R)-penehyclidine fumarate on cardiovascular function and body temperature in conscious Beagle dogs1581-15866Safety pharmacology of esculin, a cracking agent of advanced glycation end productsZHANG Hui-fang, CHEN Yu-cai, WANG Dan-shu, YUAN Tian-yi, WANG Yue-hua, FANG Lian-hua, DU Guan-hua1587-15947Progress in research and application of Sendai virus vectorFU Zhi-hao, LI Yong-hong, GAO Kai, RAO Chun-ming, WANG Jun-zhi1595-15998Progress in pharmacokinetic studies of tyrosine kinase inhibitorsZHANG Shi, WANG Ming-xia, FENG Zhang-ying1600-16079Progress in research of total synthesis and formulation of gossypolYANG Fei-fei, TANG Lu-hong1608-161210Application progress of eudragit nanoparticlesWANG Jie-min, WANG Xiong-fei, WANG Jiao, WANG Jing, CAO De-ying1613-161611Recombinant human erythropoietin promotes healing of incisions and anemia in the postoperated patients with goutSHI Ying-xu, YANG Rui-fei, YANG Bo, MENG Hong-zheng, GUO Xiao-dong, YANG Mao-wei1617-162112A randomized, double-blind, double simulation-controlled, and multi centre trial of Jieyu capsule in the treatment of mild and moderate depressionWANG Hong-yan, XU Ke, ZHANG Hong-yan1622-162513Bioequivalence studies for solid products of the oral drugs with narrow therapeutic indexDENG Ming, LIU Hui-chen1626-162914Introduction of Guidance for Industry Bioequivalence Recommendations for Specific Products issued by the US Food and Drug AdministrationLIU Qian, NAN nan, ZHU Feng-chang, CAO Xiu-ping, DING Li-xia, XU Ming-di1630-163515A comparison of in vitro dissolution profiles of lurasidone hydrochloride orally disintegrating tablets and conventional tabletsZHU Qiang, LIU Lang, ZHANG Qi-yu, ZHENG Qiang, KE Xiao1636-164016UPLC fingerprints of freeze-dried Xueshuantong for injectionLI Xue-lin, LI Yu-hui, TANG Jin-fa, MENG Xiang-le, LI Wei-xia, ZHAO Ya, CAO Ying-jie1641-164617Compatible stability of Danhong injection mixed with vitamin B6 injectionZHAO Ya, TANG Jin-fa, ZHANG Hui, LI Wei-xia, CAO Ying-jie, MENG Xiang-le, LI Xue-lin1647-165118Nintedanib ameliorates lipoplysaccharide-induced lung fibrosis in acute respiratory distress syndrome1652-165919Repeated dose toxicity study and strategies for safety assessment of compound Yizhihao particles in juvenile ratsWANG Yong, WANG Rong, LUO Yong-wei, LENG Ying-li, WANG Jing, ZHOU Li, SUN Zu-yue1660-166620Medication therapy management for outpatients with chronic kidney diseaseCHEN Shi-di, ZHAO Rong-sheng1667-1672 